LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 57.00
-0.80 (-1.38%)
Sep 8, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 4.66 billion as of September 8, 2026. Its market cap has increased by 144.40% in one year.
Market Cap
4.66B
Enterprise Value
3.95B
Revenue
414.67M
Ranking
n/a
PE Ratio
12.09
Stock Price
57.00
ChartMarket Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 4.66B, an increase of 170.51%. That is a compound annual growth rate of 4.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 4.66B | 78.12% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.70B |
| Alar Pharmaceuticals | 6.14B |
| Orient Pharma | 6.12B |
| Formosa Laboratories | 5.45B |
| Panion & Bf Biotech | 4.83B |
| Yoda Pharmaceuticals | 4.57B |
| Orient EuroPharma | 3.96B |
| Easywell Biomedicals | 3.70B |